We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$611M
AUM Growth
-$36.8M
Cap. Flow
-$10.3M
Cap. Flow %
-1.68%
Top 10 Hldgs %
33.41%
Holding
182
New
5
Increased
25
Reduced
97
Closed
9

Top Buys

Rank Stock Value
1
ALB icon
Albemarle
ALB
+$3.03M
2
ES icon
Eversource Energy
ES
+$1.91M
3
GEHC icon
GE HealthCare
GEHC
+$1.63M
4
MRNA icon
Moderna
MRNA
+$1.47M
5
APTV icon
Aptiv
APTV
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 27.82%
2 Healthcare 20.08%
3 Industrials 16.8%
4 Utilities 11.43%
5 Energy 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$36.4M 5.95%
376,824
-10,395
-3% -$990K
GLW icon
2
Corning
GLW
$128B
$22.2M 3.64%
729,950
-26,371
-3% -$862K
BMY icon
3
Bristol-Myers Squibb
BMY
$136B
$20.6M 3.37%
355,129
-4,550
-1% -$279K
CSCO icon
4
Cisco
CSCO
$433B
$20.1M 3.28%
373,225
-4,542
-1% -$245K
PFE icon
5
Pfizer
PFE
$159B
$19.1M 3.13%
576,836
-18,095
-3% -$640K
OGE icon
6
OGE Energy
OGE
$9.45B
$19.1M 3.12%
572,088
-5,550
-1% -$194K
IBM icon
7
IBM
IBM
$222B
$18.7M 3.06%
133,342
-2,087
-2% -$297K
NVS icon
8
Novartis
NVS
$292B
$18.6M 3.04%
182,690
-2,245
-1% -$228K
SLB icon
9
SLB Ltd
SLB
$85.1B
$15.8M 2.59%
271,312
-12,975
-5% -$752K
TEL icon
10
TE Connectivity
TEL
$58.7B
$13.6M 2.22%
110,030
-1,842
-2% -$246K
TSM icon
11
TSMC
TSM
$2.17T
$13.4M 2.19%
154,060
+13,250
+9% +$1.25M
XOM icon
12
ExxonMobil
XOM
$644B
$12.9M 2.11%
109,817
-1,306
-1% -$143K
INTC icon
13
Intel
INTC
$473B
$11.5M 1.89%
324,846
-3,720
-1% -$130K
MSFT icon
14
Microsoft
MSFT
$3.81T
$11.1M 1.81%
35,078
-173
-0.5% -$57.2K
MRK icon
15
Merck
MRK
$366B
$10.3M 1.68%
99,869
-950
-0.9% -$102K
AMZN icon
16
Amazon
AMZN
$2.87T
$9.53M 1.56%
74,989
-561
-0.7% -$75.2K
BCE icon
17
BCE
BCE
$21.9B
$9.49M 1.55%
248,528
+3,758
+2% +$158K
HZNP
18
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.11M 1.49%
78,762
-950
-1% -$102K
MDU icon
19
MDU Resources
MDU
$4.16B
$8.18M 1.34%
754,248
-7,762
-1% -$89.4K
AGX icon
20
Argan
AGX
$5.86B
$7.46M 1.22%
163,865
-3,287
-2% -$136K
TMO icon
21
Thermo Fisher Scientific
TMO
$230B
$7.4M 1.21%
14,628
-250
-2% -$133K
LNN icon
22
Lindsay Corp
LNN
$1.16B
$7.02M 1.15%
59,625
-565
-0.9% -$69.8K
VMW
23
DELISTED
VMware, Inc
VMW
$6.88M 1.13%
41,350
-900
-2% -$144K
ACM icon
24
Aecom
ACM
$8.9B
$6.79M 1.11%
81,742
-950
-1% -$81.9K
DIS icon
25
Walt Disney
DIS
$187B
$6.79M 1.11%
83,716
-5,200
-6% -$444K

Similar funds

John G. Ullman & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, John G. Ullman & Associates held 182 positions worth $611M, down 5.7% from $648M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2023 filing shows 5 new, 25 increased, 97 reduced and 9 closed positions. Its largest new stake was Albemarle: 15,225 shares worth $2.59M. The largest sale was Hawaiian Electric Industries, an estimated $6.95M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q3 2023 buy was Albemarle: 15,225 shares worth $2.59M.
  • John G. Ullman & Associates added most to Eversource Energy in Q3 2023, an estimated $1.91M increase.
  • John G. Ullman & Associates's biggest Q3 2023 reduction was American Tower, cutting an estimated $2.98M.
  • John G. Ullman & Associates fully exited Hawaiian Electric Industries in Q3 2023, selling an estimated $6.95M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $611M portfolio in Q3 2023.
  • John G. Ullman & Associates opened 5 new positions and closed 9 in Q3 2023.
  • John G. Ullman & Associates's portfolio value fell 5.7% quarter-over-quarter to $611M.

Based on John G. Ullman & Associates's 13F filing for Q3 2023, filed 1 Nov 2023.